English
  • Ruxolitinib

    Ruxolitinib

    Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US)
    Ruxolitinib I-Myelofibrosis Novartis Nge-6 kaJulayi, 2024
    ukubuzaiinkcukacha
  • Relugolix

    Relugolix

    Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US)
    Relugolix Umhlaza weProstatic Takeda kunye no-ASKA NgoJanuwari 24, 2024
    ukubuzaiinkcukacha
  • Rimegepant

    Rimegepant

    Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US)
    Rimegepant Intloko yeMigraine I-Biohaven NgoFebruwari 22, 2031

     

    ukubuzaiinkcukacha
  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP
    Ribociclib CAS: 737789-87-6 I-Antineoplastic Endlwini      
    ukubuzaiinkcukacha
  • Ribociclib 1374639-75-4

    Ribociclib 1374639-75-4

    Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US)
    Ribociclib 1374639-75-4 HR-positive, HER2-negative Andvance ormetastaticbreast Cancers Novartis
    Amachiza    		 NgoJuni. 27, 2028
    ukubuzaiinkcukacha
  • Rivaroxaban

    Rivaroxaban

    Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP
    Rivaroxaban I-Anticoagulant Endlwini TDP    
    ukubuzaiinkcukacha
  • Rosuvastatin Calcium

    Rosuvastatin Calcium

    Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP
    Rosuvastatin Calcium I-Hypercholesterolemia Endlwini/CEP 20705 √ CEP2015-240
    ukubuzaiinkcukacha